You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pancreatic neuroendocrine tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multi-dimensional Fragmentomic Assay for Early Detection of

Not yet recruiting
  • Pancreatic Neuroendocrine Tumor
  • Fragmentomic profiles of plasma cfDNA
  • (no location specified)
Apr 27, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

Recruiting
  • VHL Pancreatic Neuroendocrine Tumors
  • +2 more
  • 68-Gallium DOTATATE
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

Completed
  • Pancreatic Neuroendocrine Tumor G2
  • Octreotide LAR
  • (no location specified)
Oct 17, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
  • long-acting Octreotide.
  • (no location specified)
May 22, 2023

Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning

Recruiting
  • Nonfunctional Pancreatic Neuroendocrine Tumor
  • +2 more
  • EUS-guided ethanol ablation
  • EUS-guided lauromacrogol ablation
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Sep 30, 2022

Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

Not yet recruiting
  • Pancreatic Neuroendocrine Tumor
  • Pancreas Cancer
  • cytoreductive surgery
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Nov 8, 2022

Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)

Recruiting
  • Multiple Endocrine Neoplasia Type 1
  • Pancreatic Neuroendocrine Tumor
  • EUS-guided fine-needle injection
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Sep 24, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • +4 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jan 14, 2023

Pancreatic Neuroendocrine Tumors and Carcinomas

Recruiting
  • Cancer of Pancreas
    • Strasbourg, France
      Service d'Oncologie - CHU de Strasbourg - France
    Jan 31, 2022

    Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

    Recruiting
    • Neuroendocrine Tumors
    • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 19, 2023

    Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

    Not yet recruiting
    • Metastatic Pancreatic Neuroendocrine Tumor
    • Unresectable Pancreatic Neuroendocrine Carcinoma
    • Lutetium Lu 177 Dotatate
    • +4 more
    • (no location specified)
    Feb 10, 2022

    Development of New Personalised 3D Preclinical Models of

    Recruiting
    • Pancreatic Neuroendocrine Tumor
      • Milan, MI, Italy
        IRCCS San Raffele Institute
      Nov 2, 2023

      Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • +6 more
      • (no location specified)
      Aug 4, 2023

      Neuroendocrine Tumor of Pancreas (Disorder), Neuroendocrine Tumor Grade 1 Trial in Marseille (Radiofrequency ablation)

      Recruiting
      • Neuroendocrine Tumor of Pancreas (Disorder)
      • Neuroendocrine Tumor Grade 1
      • Radiofrequency ablation
      • Marseille, France
        Institut Paoli Calmettes
      Jan 5, 2022

      Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail

      Recruiting
      • Non Functioning Pancreatic Endocrine Tumor
      • Histopathological review, long-term prognosis and quality of life follow-up
      • Shanghai, Shanghai, China
        Department of Pancreatic Surgery, Fudan University Shanghai Canc
      Jun 8, 2023

      Pancreatic Neuroendocrine Tumors, WHO Grade I-II Trial in Oslo (Radio frequency ablation)

      Recruiting
      • Pancreatic Neuroendocrine Tumors, WHO Grade I-II
      • Radio frequency ablation
      • Oslo, Norway
        Oslo University Hospital
      Feb 7, 2022

      Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic

      Recruiting
      • Hepatocarcinoma
      • Pancreatic Tumor
      • Hepatocellular carcinoma
      • +2 more
      • Clichy, France
        Hôpital Beaujon
      Mar 20, 2023

      Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

      Not yet recruiting
      • Digestive System Neuroendocrine Tumor G1
      • +5 more
      • Tumor Debulking
      • +5 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Aug 23, 2023

      Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

      Not yet recruiting
      • Neuroendocrine Tumors
      • +4 more
      • Newport Beach, California
      • +2 more
      Aug 16, 2023

      Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

      Active, not recruiting
      • Carcinoid Tumor
      • Pancreatic Neuroendocrine Tumor
      • Boston, Massachusetts
      • +1 more
      Jul 15, 2022

      Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

      Terminated
      Has Results
      • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
      • Bruxelles, Belgium
      • +23 more
      Dec 21, 2022

      Metastatic Malignant Tumor in the Liver, Pancreatic Neuroendocrine Tumor, Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Trial

      Recruiting
      • Metastatic Malignant Neoplasm in the Liver
      • +4 more
      • Ames, Iowa
      • +5 more
      Dec 3, 2021

      Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

      Recruiting
      • Neuroendocrine Tumors
      • +4 more
      • [212Pb] VMT-α-NET
      • [203Pb] VMT-α-NET SPECT/CT
      • Iowa City, Iowa
        Holden Comprehensive Cancer Center at the University of Iowa
      Nov 30, 2023

      Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)

      Recruiting
      • Neuroendocrine Tumor Grade 3
      • +2 more
      • Tianjin, Tianjin, China
        Rui Liu
      Nov 17, 2022